Literature DB >> 2973787

CSF-1 and C-FMS gene expression in human carcinoma cell lines.

J Horiguchi1, M L Sherman, A Sampson-Johannes, B L Weber, D W Kufe.   

Abstract

The macrophage-specific colony stimulating factor CSF-1 is required for the growth and differentiation of monocytes. The cell surface receptor for CSF-1 is identical to the product of the c-fms proto-oncogene. The present studies have monitored CSF-1 and c-fms expression in human carcinoma cell lines. Two of three human ovarian carcinoma cell-lines expressed multiple species of CSF-1 mRNA. Furthermore, detection of CSF-1 transcripts was associated with secretion of CSF-1 protein that was increased after phorbol ester treatment. CSF-1 mRNA was also detectable in 4 breast and 2 lung carcinoma cell lines. In contrast, c-fms expression was found only in SK-Br-3 breast carcinoma cells. Similar studies in 2 human choriocarcinoma cell lines demonstrated the presence of c-fms, but not CSF-1, transcripts. While phorbol ester treatment was associated with increased c-fms mRNA levels in choriocarcinoma cells, this agent had no effect on CSF-1 expression. These findings indicate that: 1) CSF-1 expression is frequent in human ovarian, breast and lung carcinoma cells; and 2) coexpression of the CSF-1 and c-fms genes, as found in monocytes is infrequent in malignant epithelial and choriocarcinoma cell lines.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2973787     DOI: 10.1016/s0006-291x(88)80060-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.

Authors:  Ruth Schwaninger; Cyrill A Rentsch; Antoinette Wetterwald; Geertje van der Horst; Rutger L van Bezooijen; Gabri van der Pluijm; Clemens W G M Löwik; Karin Ackermann; Walter Pyerin; Freddie C Hamdy; George N Thalmann; Marco G Cecchini
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  Transcriptional and posttranscriptional regulation of macrophage-specific colony stimulating factor gene expression by tumor necrosis factor. Involvement of arachidonic acid metabolites.

Authors:  M L Sherman; B L Weber; R Datta; D W Kufe
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study.

Authors:  S M Scholl; R Lidereau; A de la Rochefordière; C C Le-Nir; V Mosseri; C Noguès; P Pouillart; F R Stanley
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1.

Authors:  B M Kacinski; D Carter; K Mittal; L D Yee; K A Scata; L Donofrio; S K Chambers; K I Wang; T Yang-Feng; L R Rohrschneider
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

5.  Detection of fms-oncogene-specific tyrosine kinase activity in human leukemia cells.

Authors:  T Tamura; H Brost; A Käbisch; F Lampert; A Hadwiger-Fangmeier; H Niemann
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

6.  Tumoricidal effect of human macrophage-colony-stimulating factor against human-ovarian-carcinoma-bearing athymic mice and its therapeutic effect when combined with cisplatin.

Authors:  T Adachi; H Mano; Y Shinohara; T Nakanishi; T Suzuki; K Ino; N Kato; T Okamoto; A Nawa; S Goto
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

7.  The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines.

Authors:  Andrea Morandi; Valentina Barbetti; Maria Riverso; Persio Dello Sbarba; Elisabetta Rovida
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

8.  CSF-1 receptor-dependent colon development, homeostasis and inflammatory stress response.

Authors:  Duy Huynh; Dilara Akçora; Jordane Malaterre; Chee Kai Chan; Xu-Ming Dai; Ivan Bertoncello; E Richard Stanley; Robert G Ramsay
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

9.  Constitutive production of multiple colony-stimulating factors in patients with lung cancer associated with neutrophilia.

Authors:  N Adachi; K Yamaguchi; T Morikawa; M Suzuki; I Matsuda; M K Abe
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

10.  Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer.

Authors:  S M Scholl; C H Bascou; V Mosseri; R Olivares; H Magdelenat; T Dorval; T Palangié; P Validire; P Pouillart; E R Stanley
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.